Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

29
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
29
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

203
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
203
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

53
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
53
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

69
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
69
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

35
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
35
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

61
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
61

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Perspectives From an Expert-Guided Discussion on Maximizing the Research Potential of Small Biopsy Tissue.

JCO precision oncology·2026
Same author

Multiplex immunofluorescence microscopy assays for pharmacodynamic assessment of MET tyrosine kinase activation in the plasma membrane and nucleus.

PloS one·2026
Same author

Mass Spectrometric Detected Cancer Proteins as Resources for Cancer Research.

Journal of proteome research·2026
Same author

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Dynamic switching of apoptosis-modulating BIM heterodimers in response to BH3 mimetics in xenograft models of hematologic malignancies.

Molecular cancer therapeutics·2026
Same author

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.

Cancer chemotherapy and pharmacology·2026

相关实验视频

Updated: May 17, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

922

药物反应预测中的数据不平衡:深度学习环境中的多目标优化方法.

Oleksandr Narykov1, Yitan Zhu1, Thomas Brettin1

  • 1Computing, Environment and Life Sciences, Argonne National Laboratory, 9700 S Cass Ave, Lemont, IL 60439, United States.

Briefings in bioinformatics
|April 3, 2025
PubMed
概括

这项研究引入了一种新的多目标优化方法,以改善抗癌药物反应预测 (DRP) 模型. 通过解决数据不平衡,该方法提高了针对个性化医学和药物发现的深度学习模型性能.

关键词:
深度学习是一种深度学习.药物反应预测 药物反应预测机器学习是机器学习.多目标优化多目标优化虚拟选是虚拟的选.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.6K

相关实验视频

Last Updated: May 17, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

922
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.6K

科学领域:

  • 计算生物学是一种计算生物学.
  • 机器学习在瘤学中
  • 药物的发现和开发.

背景情况:

  • 药物反应预测 (DRP) 将患者遗传与药物有效性联系起来,这对于个性化癌症治疗至关重要.
  • 与其他AI领域相比,抗癌DRP由于广泛的致病机制和有限的数据深度而复杂.
  • 现有的DRP模型与数据不平衡作斗争,阻碍了概括性和临床应用.

研究的目的:

  • 制定解决DRP数据集数据不平衡的策略.
  • 提高基于深度学习的DRP模型的通用性和性能.
  • 将DRP重新定义为跨多种药物的多目标优化问题.

主要方法:

  • 实施了由损失 (MOORLE) 损失函数规范的多目标优化.
  • 将MOORLE损失函数集成到一个深度学习模型架构中.
  • 评估了抗癌药物查数据集的方法.

主要成果:

  • 通过解决数据不平衡,证明了DRP模型的改进性能.
  • 多目标优化策略增强了模型的概括性.
  • 拟议的方法显示出用于推进药物发现和个性化医学的实用性.

结论:

  • 摩尔尔方法有效地解决了DRP中的数据不平衡问题.
  • 这一策略增强了针对抗癌药物反应预测的深度学习模型性能.
  • 这项工作为改善药物发现和医疗保健结果提供了一条途径.